BusinessInspire continues expansion of partnerships with nonprofit advocacy organizationsBy Nasdaq OMXDec 28, 2017, 12:00 PM UTC
BusinessAsklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International MeetingBy Nasdaq OMXDec 8, 2017, 2:00 PM UTC
BusinessZynerba Pharmaceuticals Announces Positive Top Line Results in ZYN002 Open Label Phase 2 FAB-C Study in Children with Fragile X SyndromeBy Nasdaq OMXSep 28, 2017, 10:30 AM UTC
BusinessAchillion to Present at the 2017 Leerink Partners Rare Disease Roundtable SeriesBy Nasdaq OMXSep 20, 2017, 10:05 AM UTC
BusinessTaconic Biosciences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual DisabilityBy Nasdaq OMXAug 31, 2017, 9:22 PM UTC
BusinessStrongbridge Biopharma plc Provides Updates on KEVEYIS® Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 7, 2017, 11:00 AM UTC
BusinessLogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric PatientsBy Nasdaq OMXJun 28, 2017, 6:03 AM UTC
